Baric Transcribed Interview (Redacted) — page 14

DC.Scheduling@LexitasLegal.com MS. SALAZAR: I was just wondering if that was the same, you know, the same type of research that you were engaged in on the 4th, or that you were discussing on the 4th. Is that the same? DR. BARIC: Yes, that's the same. That's the same phone call, yes. That's absolutely true. MS. SALAZAR: Okay. And so on the 4th you had that call, and then I know that you had a call, I think, with Erik Stemmy on the 7th? DR. BARIC: Around the 7th. There were a lot of phone calls in the first three weeks of January. But certainly I did talk to him. The exact date, I'd have to look at my notes. I thought it was more around the 11th or 12th, but it could easily be the 7th. MS. SALAZAR: Was that the first NIH employee that you had spoken to, or had you spoken with others? DR. BARIC: Somewhere around those dates I also talked to Barney Graham at the VRC, because we'd been working since about 2017 on mRNA-LNP-based vaccines using MERS coronavirus as, in essence, a paradigm model for how to develop an effective vaccine against coronavirus. MS. SALAZAR: Did you already have a vaccine developed with them, or was it still -- DR. BARIC: We had an mRNA vaccine for MERS coronavirus that had been tested in mice, both young and